TY  - GEN
AU  - Ferry,D R
AU  - Deakin,M
AU  - Baddeley,J
AU  - Daryanani,S
AU  - Bramhall,S
AU  - Anderson,D A
AU  - Wakelam,M J
AU  - Doran,J
AU  - Pemberton,G
AU  - Young,A M
AU  - Buckels,J
AU  - Kerr,D J
TI  - A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
SN  - 0923-7534
PY  - 2001///0215
KW  - Antineoplastic Agents
KW  - pharmacokinetics
KW  - Benzoquinones
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Evaluation
KW  - Female
KW  - Humans
KW  - Linoleic Acid
KW  - blood
KW  - Lipoxygenase Inhibitors
KW  - Male
KW  - Middle Aged
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Thromboxane B2
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1023/a:1008303715515
ER  -